A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer. [electronic resource]
Producer: 20160215Description: 357-67 p. digitalISSN:- 1879-114X
- Administration, Sublingual
- Adult
- Aged
- Analgesics, Opioid -- administration & dosage
- Breakthrough Pain -- drug therapy
- Cross-Over Studies
- Disease Management
- Double-Blind Method
- Female
- Fentanyl -- administration & dosage
- Humans
- Male
- Middle Aged
- Neoplasms -- drug therapy
- Pain Management
- Pain Measurement
- Tablets
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.